Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.
Although antibiotics from different classes are frequently prescribed in combination to prevent the development of resistance amongst Cystic Fibrosis (CF) respiratory pathogens, there is a lack of data as to the efficacy of this approach. We have previously shown that a 4:1 (w/w) combination of fosf...
Guardado en:
Autores principales: | Gerard McCaughey, Paul Diamond, J Stuart Elborn, Matt McKevitt, Michael M Tunney |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76a5eef5475745beacace83edff650e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
por: VanDevanter DR, et al.
Publicado: (2011) -
Elimination of fosfomycin during dialysis with the Genius system in septic patients
por: T. Dimski, et al.
Publicado: (2021) -
Electrochemical and Structural Modifications of Humic Acids in Aerobically and Anaerobically Incubated Peat
por: Carlo Bravo, et al.
Publicado: (2021) -
Energy consumption in anaerobic and aerobic based wastewater treatment plants in Italy
por: Ezio Ranieri, et al.
Publicado: (2021) -
Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Nermin Kamal Saeed, et al.
Publicado: (2021)